CompletedNot Applicable

Effectiveness of a Multimodal Intervention With Simulation for Learning Home Health Nursing Care of Patients With Multimorbidity and Heart Failure

Spain80 participantsStarted 2025-03-10

Plain-language summary

The goal of this clinical trial is to evaluate the efficacy of a multimodal intervention with high-fidelity simulations on home health nursing in improving the care of multipathological patients with heart failure in nursing students. The main questions it aims to answer are: * Does using validated simulation scenarios on multipathological patients with heart failure improve care competencies in nursing students? * Does knowledge of scientific evidence and healthcare protocols improve nursing students' performance in the simulator? Researchers will compare a multimodal intervention with high-fidelity simulations on home health nursing to conventional intervention (theoretical teaching) to see if nursing students better learn competencies related to the care of patients with multimorbidity and heart failure during the home health nursing. Participants will: * Experience simulations on validated simulation scenarios on multipathological patients with heart failure (All participants). * Reflect on the intervention performed on the simulator through individual and group debriefings (Experimental Group). * Learn about the main scientific evidence and international and national protocols related to comorbidities and health failure (Experimental Group).

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Nursing students enrolled in the subject "Family and Community Nursing I". Exclusion Criteria: * Lack of attendance since the beginning of the course. * Failure to follow the instructions of the instructors during the course of the study. * Voluntary withdrawal from the study during the study or declaring non-participation.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Learning

Timeframe: From enrollment to the end of intervention at 4 weeks.

Empathy

Timeframe: From enrollment to the end of treatment at 4 weeks.

Trial details

NCT IDNCT06855719

SponsorUniversity of Cadiz

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-30

View on ClinicalTrials.gov More Multimorbidity trials